chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Monday, I started feeling bad. I had a low-grade consistent headache. I started feeling hyper, it could have been more of an adrenaline rush every so often. It would dissipate and then come back. I suspected it had to do with my blood pressure. the next day I exercised for 45 minutes That Wednesday I woke up feeling fair, i took my morning medications and within a n hour I started to feel bad. Coincidentally had a carotid doppler and that test came back normal. I get one every two years. Thursday night I started feeling bad again, I woke up feeling hyper. I slept fine but I was having this feeling all over. I also had a headache. I decided to make an appointment with my primary who wasn't available, so I went to urgent care. I went there. They took all my blood pressure readings, and they were a little but high. It was high enough to where the doctor might want to increase my blood pressure medications. On that Friday I felt hyper again, I had a headache the whole day. I was very disappointed with that. Saturday and Sunday I felt better. Today I feel fine. I had scheduled blood work done today for appointments that I have scheduled. the feeling that I had was alarming. I took two COVID-19 test that came back negative. I'll will be going over this information with my primary doctor next week. Another symptom I have noticed is that my voice gets a little tired and out of breath.
I read a research report which links Myasthenia gravis with Covid-19 vaccine. I was recently diagnosed with MG.  Symptoms (double vision & dizziness) appeared suddenly 1st of September after 2 Moderna shots. Long wait to see & get a diagnosis from a neuro-ophthalmologist. I would like to get a reaction from you.  My 52 yr old son may have been affected also.
Information has been received from a physician concerning an 8 year old male who on 25-JUN-2007 was vaccinated with a dose of ZOSTAVAX rather than a dose of VARIVAX. No product confusion was discovered, only a medication error. The physician was not the physician that ordered or administered the vaccination. Unspecified medical attention was sought. No problems were reported. A product quality complaint was not involved. Additional information has been requested.
After 24 hours developed swelling of entire (L) upper arm. A week after Flu shot developed periorbital edema. Seen in office 10/14 (+) proteinuria. Sent to ER - admitted x 24 hours. Dx minimal change nephrotic syndrome. Rx Prednisone.
The vial was initially stored in the refrigerator on 01-Mar-2023 and vaccine was administered on 04-Apr-2023; no adverse event; Staff gave an expired vaccine to a patient/Dose administered after 30-day Use By Date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Staff gave an expired vaccine to a patient/Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 01-Mar-2023 and vaccine was administered on 04-Apr-2023) and NO ADVERSE EVENT (no adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 04-Apr-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 04-Apr-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Staff gave an expired vaccine to a patient/Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 01-Mar-2023 and vaccine was administered on 04-Apr-2023) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Staff gave an expired vaccine to a patient/Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 01-Mar-2023 and vaccine was administered on 04-Apr-2023) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Staff gave an expired vaccine to a patient/Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 01-Mar-2023 and vaccine was administered on 04-Apr-2023).    No concomitant medications were reported.     The vial was initially stored in the refrigerator on 01-Mar-2023. The BUD  of Bivalent vail was reported as 01-Apr-2023.  No treatment medications were reported
After receiving H1N1 mist intranasally Pt. presented with circumoral rash - no other complaints.
Child became restless and irritable the morning following vaccination. This continued for two days. Child back to normal.
On April 19th, 16 days after vaccine administered, massive headaches began that left me bed ridden for roughly 2 weeks to a month afterwards. Severe headaches lasted all day with no breaks. Only relief I would have would be from laying down with head in a certain position.   A month after initial symptoms, the pain started to subside, but very slowly, taking several more weeks to calm down and to feel reduction in pain. Pressure would also set in around brain when pain was becoming less.  Several tests had been done after symptoms began which included: Bloodwork Lipid CT Scan without contrast CT Scan with contrast MRI without contrast  On June 15th, I was notified by my Neurologist that the MRI, which had been performed on June 10th, had showed a mild stroke had recently occurred.  I am now on blood pressure medication, as well as aspirin 81, reduce the likelihood of another stroke.
Dizziness; Nauseous; Headache; This case was reported by a other health professional via sales rep and described the occurrence of dizziness in a 18-year-old female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   Co-suspect products included Men B NVS (Bexsero) for prophylaxis, meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis and HPV 16-18 (HPV vaccine) for prophylaxis.   On 23rd February 2022, the patient received Menveo, Bexsero, Bexsero Pre-Filled Syringe Device and HPV vaccine. On an unknown date, less than a week after receiving Menveo, Bexsero and Bexsero Pre-Filled Syringe Device and unknown after receiving HPV vaccine, the patient experienced dizziness, nausea and headache. On an unknown date, the outcome of the dizziness, nausea and headache were unknown.   It was unknown if the reporter considered the dizziness, nausea and headache to be related to Menveo, Bexsero, Bexsero Pre-Filled Syringe Device and HPV vaccine. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The case was reported by patient's mother. The patient after vaccination started complaining of dizziness, was nauseous and had headache.  The patient also received the HPV vaccine. The mother said all 3 vaccines (Menve, Bexsero, HPV) were given at the same time.  The reporter not sure which product was causing adverse event. The reporter consented to follow up.
She had redness at the injection site that had spread up her arm (toward shoulder). We recommended BENADRYL or CLARITIN and a topical hydrocortisone. I also recommended putting ice on the area.
no appetite; ill; earache; high blood pressure; dehydrated; No fever, but felt very warm; headache; rash; nausea; fatigue; body aches; This spontaneous case was reported by a patient and describes the occurrence of DECREASED APPETITE (no appetite), MALAISE (ill), EAR PAIN (earache), HYPERTENSION (high blood pressure) and DEHYDRATION (dehydrated) in a 66-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 vaccines (Dose 1) on 29-Mar-2021, Moderna COVID-19 vaccines (Dose 2) on 26-Apr-2021 and Moderna COVID-19 vaccines (Dose 3) on 28-Dec-2021; for Product used for unknown indication: Flu vaccine (3 weeks prior). Past adverse reactions to the above products included No adverse event with Flu vaccine, Moderna COVID-19 vaccines, Moderna COVID-19 vaccines and Moderna COVID-19 vaccines.    On 18-Oct-2023, the patient received fourth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 19-Oct-2023, the patient experienced DECREASED APPETITE (no appetite), MALAISE (ill), EAR PAIN (earache), HYPERTENSION (high blood pressure), DEHYDRATION (dehydrated), FEELING HOT (No fever, but felt very warm), HEADACHE (headache), RASH (rash), NAUSEA (nausea), FATIGUE (fatigue) and MYALGIA (body aches). At the time of the report, DECREASED APPETITE (no appetite), MALAISE (ill), EAR PAIN (earache), HYPERTENSION (high blood pressure), HEADACHE (headache), RASH (rash), NAUSEA (nausea), FATIGUE (fatigue) and MYALGIA (body aches) had not resolved and DEHYDRATION (dehydrated) and FEELING HOT (No fever, but felt very warm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Oct-2023, Blood pressure measurement: 165.     For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Reported that she saw her doctor on 20-Oct-2023 and started taking blood pressure medication.
Intermittant substernal "aching" 1 to 3 on pain scale of 10 on 3/14/03 and continues to present. History of hypertension. Working diagnosis is inferior wall cardiac ischemia. Patient was not on beta blockers, digitalis nor long-acting nitrate.
Pts. came in to the clinic to get his 3rd dose for Covid 19 vaccine, check his electronics medical records pts. received Moderna Covid 19 vaccine 1st dose on 1/21/2021 and 2nd dose on 2/18/2021 with our clinic . Pts. qualified for the 3rd dose with our company policy due to medical Dx so 3rd dose was given. When auditing we found out that pts. received Moderna Covid 19 on 3/26/2021 and 4/23/2021.  Pts. received a total of 5 doses,
patient is scheduled to receive the second dose of GARDASIL 9 approximately 4 years after receiving the first dose; No additional AE reported; This spontaneous report was received from a pharmacist and refers to an 18-year-old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided.  On an unknown date in 2017 (reported as approximately 4 years ago, at the age of 14 years old), the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (formulation, strength, dose, frequency, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis.  At the reporting time, the patient did not finished vaccination schedule with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) and was sheduled to receive the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). All three doses would not be given within a 1-year period (inappropriate schedule of product administration). No additional adverse event (AE) reported.
I had had an exacerbation of the Riter's the last couple of months, but after the 3rd vaccine it was much worse. I called my doctor because it was uncomfortable. 1st visit was phone visit. It was a flare that I had had in months. I do have a flare up from time to time but this was . Pain and extra urinary pain - urine was normal; blood was normal. Tt's autoimmune (infections don't show on the testing - always negative); non bacterial inflammation - it feels like prostrate/urethra and it is very uncomfortable. It feels like a bladder infection, it feels like that but it's not an infection. This time, my joints were okay. Doctor bumped up the treatment meds: Sulfasalazine - anti-inflammatory - increased and ibuprofen at higher doses too. And this combination at higher doses has pretty much calmed it down. Luckily my blood has been okay on repeated tests with the higher doses of these. I asked the doctor if it could be related to vaccine and he told me he also had Rheumatoid Arthritis patients that had experienced a flare that he thought was possible that it was related. The first two vaccines, the first one - malaise and low grade fever a day or two; the 2nd vaccine - I had hives and felt icky for a day; Doctor told me to take antihistamine for that. I have been checked for my antibody levels - and she told me that I had the antibody levels that she ( my internist that I see)  had ever seen (this was two or three months after the second vaccine). I will have follow up in three weeks with more blood work.
Patient reports the immunization site is red, swollen, hot. Patient could not move arm until today. She took 2 ibuprofen tablets and today she is able to move it. She says this usually happens with most immunizations. She reports no difficulty breathing or chest pain.
Patient received 1st dose of Moderna vaccine on 3.2.2021. Patient has a subdermal implant (Nexplanon) and does not regularly have menstrual cycles. Patient reports the morning after she received the vaccine, she started her period. Patient contacted provider. Nexplanon was implanted 8/2018, and is due to be replaced this year.
Pfizer x 3. Tested positive for Covid 03/19/2022. Admitted to Medical Center on 03/19/2022. Expired on 03/22/2022 while still hospitalized.
The vaccine was given on Thursday morning. She experienced a fever on Thursday night. An itchy rash developed on the wrists Saturday night. A small itchy rash developed along the underwear and bra line on Sunday afternoon, this went away for the most part with benedryl. Rash appeared slightly for the remainder of the weekend, but appeared worse on Monday morning. On Monday morning the rash appeared to be raised and very itchy, she went to the doctors office at around 10:15 Monday morning and the rash looked to have disappeared for the most part. Then, Monday afternoon around 3pm the rash appeared again, this time extremely itchy and spreading rapidly. By the time we got to the walk in clinic at 7:45pm the urticarial rash has spread almost completely over the stomach, feet, armpits, inner thighs, chest, and wrists. This was a warm, symmetrical rash that was extremely itchy. The PA at the walk in prescribed a prednisone regimen.
G40.109 PARTIAL EPILEPSY 4/17/2022 PRESSURE ULCER OF LEFT LOWER LEG, UNSPECIFIED STAGE R09.02 HYPOXIA 4/17/2022 PRESSURE ULCER OF LEFT LOWER LEG, UNSPECIFIED STAGE G40.109 PARTIAL EPILEPSY 4/17/2022 PARTIAL EPILEPSY R09.02 HYPOXIA 4/17/2022 PARTIAL EPILEPSY G40.109 PARTIAL EPILEPSY 4/17/2022 METABOLIC ENCEPHALOPATHY R09.02 HYPOXIA 4/17/2022 METABOLIC ENCEPHALOPATHY
Arm hurt; Injection site was swollen; Injection site was itching; Injection site was red, spread out a bit; Low-grade fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit) and PYREXIA (Low-grade fever) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ETHINYLESTRADIOL, NORETHISTERONE ACETATE (LOESTRIN) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit), PYREXIA (Low-grade fever) and CHILLS (Chills). At the time of the report, VACCINATION SITE PAIN (Arm hurt), VACCINATION SITE SWELLING (Injection site was swollen), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE ERYTHEMA (Injection site was red, spread out a bit), PYREXIA (Low-grade fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information provided.
The day after the administration of the vaccine, the fever began, the patient claim that he had no blood pressure problems. He was given acetaminophen every 4 hrs. and vitamin C and D. On February 11, he was stabilized, he had his regular meals without any problem but in the afternoon his temperature rose again and they put him to bed. The patient died that same afternoon around 4:00 pm
About 12 hours after receiving the shot, I had intense/severe body pains, skin sensitivity and shakes, which lasted about 30 minutes. More moderate body aches continued for about 2-3 days after.
3cm x 2cm area of erythema with some swelling (R) lateral thigh.
Aching in left upper arm and shoulder within 6 hours, development of swelling after 4 days, diagnosed with left upper extremity proximal DVT day 8 after vaccine.
This spontaneous report was received from a physician referring to a unspecified patients of unknown age. No pertinent medical history and concurrent conditions reported. On an unknown date the unspecified patients were vaccinated with improperly stored GARDASIL injection (dose not reported). No other concomitant therapies reported. The outcome of the event was unknown. No PQC reported. Additional information has been requested.
c/o numbness approx 1/2 hr p/inject; then severe migraine h/a; by evening had many hives; started on liquid DPH;
I61.9 - Hemorrhagic stroke (CMS/HCC) R29.810 - Facial weakness
Postvaccination fever on 2022-10-21, Acute nonspecific idiopathic pericarditis on 2022-11-03.
Severe headache and fatigue which I understand is normal but after both vaccinations both of my eyes hurt so bad around the edges that even my eyelashes hurt to the touch.  The pharmacist suggested I report it
Still has bruising in arm 2 weeks later. Has had flu-type symptoms. Is lethargic. Sleeping heavier than normal (normally a light sleeper.) Was somewhat disoriented for a time after the shot. That seems to be improvin, but still is ongoing.. No appetite, but has eaten small amounts. Has been drinking fluids.
Felt fine all day after shot. Middle of the night I woke up and felt like someone had punched me in the arm and I had chills/aches. Went to work next day but only lasted two hours. Lots of aches, chills. Second day was okay 80%, Third day was okay.
patient indicates she is starting to feel hot in neck area up to her arm. She had watery eyes. Pharmacist assisted her and asked if she has any condition in her eyes : she said no. She said she felt weird and drowsy. Pharmacist asked if she was allergic to something and she said yes. Pharmacist administered 50mg of Benadryl IM on arm. She started to feel better.
fever 102, h/a, general body aches, site sore;no edema, no erythema, dizziness, fatigue;DPH & advil given;
My arm started aching initially. Throughout the day, it started to swell and get itchy. The area of the injection site started turning red. I called Friday - and advice nurse said to said to take Ibuprofen and do ice pack and Benadryl. The redness started moving down my arm and I went to Urgent Care on Saturday 16th. Dr looked at it and said to keep an eye on it. He suggested the same treatment as the advice nurse had advised. The treatments for it helped with the symptoms. The swelling took about a week to go down and the itching stopped after two weeks.
Patient reported redness and swelling on 8/3/19. Came back to pharmacy 8/4/19 and two more spots had appeared and they were warm to the touch. Recommended patient go to immediate care facility. Patient was diagnosed with cellulitis and prescribed caphalexin 500 mg twice daily for 10 days.
5 weeks after injection patient developed a non-painful, non colored lump/mess under the skin roughly sand dollar sized.
cough; This is a spontaneous report from a contactable consumer or other non hcp. A 12-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 12Jul2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated that her son received his first dose on 12Jul2021 and on 20Jul2021 they both tested positive for Covid and experienced cough on an unspecified date. Her son was scheduled for his second dose today. The reporter asked if the patient could receive his second dose today if he still has a cough and asked if someone gets Covid after their first dose do they still have to get the second dose. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: positive on 20Jul2021. The outcome of the events was not recovered.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
This spontaneous report was received from a nurse via company representative regarding a male patient of an unknown age. The patient's relevant medical history, current conditions, concomitant medications and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with the third dose of GARDASIL 9 (strength, frequency, route of administration, lot# and expiry date were not reported) for prophylaxis. On an unknown date, the patient had a seizure shortly after vaccination. It was unknown if patient sought for any medical attention or received treatment for the event. The outcome of seizure was unknown. Causality assessment was not reported. No product quality complaint (PQC) was involved. Upon internal review, seizure was determined to be medically significant.
evening of vaccination large painful knot forming on right brachial plexus, swollen.  pain level 6.  Symptoms escalated throughout the evening and into the next day, muscle pain on affected side increasing.  The following morning, accessory muscles of respiration gradually tightening, inspiration particularly painful in comparison to expiration.  Pain level at least 7 or 8 throughout the day.  Unable to perform activities of daily living, rested on bed throughout the day and focused on breathing and relaxation.
After receiving Td on 9/24/04 pt. experienced fever and swelling from shoulder to elbow in arm that was vaccinated.
Fever of 102.5 after taking Aleve Chills Headache Body aches  Fatigue/Tiredness-had to go to bed
Patient was given a vaccination of COVID 19 vaccine (Moderna), he's only 17 years old and 9 months.  Indication for this vaccine is 18 years old and older.  Discrepancy was discovered during billing.  Patient mother was immediately informed, per mother there were no adverse effects other than a sore arm.  Mother is only concerned about the second dose (to vaccinate or not).  A call was placed to the doctor, she was informed about the incident.  She stated that a trial is being done to 12 -18 years now, and was not so concern since the patient is almost 18.  However, she will inquire to one of her colleague regarding the recommendation to vaccinate or not for the second dose.